Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Jun;103(2):1303–1308. doi: 10.1111/j.1476-5381.1991.tb09784.x

CGP 35348, a new GABAB antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen.

M Malcangio 1, C Ghelardini 1, A Giotti 1, P Malmberg-Aiello 1, A Bartolini 1
PMCID: PMC1908386  PMID: 1653069

Abstract

1. CGP 35348, a new GABAB antagonist, was examined on antinociception induced by (+/-)-baclofen by use of the hot plate and writhing tests in mice and the paw pressure test in rats. CGP 35348 was also studied in mice on (+/-)-baclofen-induced impairment of rota-rod performance. 2. CGP 35348, injected either i.p. (60-100 mg kg-1 in mouse) or intracerebroventricularly (i.c.v.) (0.5-2.5 micrograms per mouse; 25 micrograms per rat) prevented (+/-)-baclofen-induced antinociception. 3. CGP 35348 did not modify oxotremorine- and morphine-induced antinociception in mice and rats. 4. CGP 35348 (2.5 micrograms i.c.v. per mouse) also prevented (+/-)-baclofen-induced impairment of the rota-rod test. 5. Two other GABAB antagonists, phaclofen (50 micrograms i.c.v. per mouse) and 2-OH-saclofen (2.5 micrograms-10 micrograms i.c.v. per mouse) did not modify (+/-)-baclofen-induced antinociception. 7. These results suggest that, at present, CGP 35348 is the only compound able to antagonize (+/-)-baclofen-induced antinociception.

Full text

PDF
1303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowery N. GABAB receptors and their significance in mammalian pharmacology. Trends Pharmacol Sci. 1989 Oct;10(10):401–407. doi: 10.1016/0165-6147(89)90188-0. [DOI] [PubMed] [Google Scholar]
  2. Corli O., Roma G., Bacchini M., Battagliarin G., De Lorenzi P. P. Il Baclofen come analgesico negli interventi di dilatazione, aspirazione e curettage uterino. Minerva Anestesiol. 1984 Jul-Aug;50(7-8):401–405. [PubMed] [Google Scholar]
  3. Cutting D. A., Jordan C. C. Alternative approaches to analgesia: baclofen as a model compound. Br J Pharmacol. 1975 Jun;54(2):171–179. doi: 10.1111/j.1476-5381.1975.tb06926.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dutar P., Nicoll R. A. A physiological role for GABAB receptors in the central nervous system. Nature. 1988 Mar 10;332(6160):156–158. doi: 10.1038/332156a0. [DOI] [PubMed] [Google Scholar]
  5. Giuliani S., Evangelista S., Borsini F., Meli A. Intracerebroventricular phaclofen antagonizes baclofen antinociceptive activity in hot plate test with mice. Eur J Pharmacol. 1988 Sep 13;154(2):225–226. doi: 10.1016/0014-2999(88)90105-7. [DOI] [PubMed] [Google Scholar]
  6. HALEY T. J., MCCORMICK W. G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother. 1957 Mar;12(1):12–15. doi: 10.1111/j.1476-5381.1957.tb01354.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hammond D. L., Drower E. J. Effects of intrathecally administered THIP, baclofen and muscimol on nociceptive threshold. Eur J Pharmacol. 1984 Aug 3;103(1-2):121–125. doi: 10.1016/0014-2999(84)90197-3. [DOI] [PubMed] [Google Scholar]
  8. Hill R. C., Maurer R., Buescher H. H., Roemer D. Analgesic properties of the GABA-mimetic THIP. Eur J Pharmacol. 1981 Jan 16;69(2):221–224. doi: 10.1016/0014-2999(81)90419-2. [DOI] [PubMed] [Google Scholar]
  9. Hwang A. S., Wilcox G. L. Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord. J Pharmacol Exp Ther. 1989 Mar;248(3):1026–1033. [PubMed] [Google Scholar]
  10. Kerr D. I., Ong J., Johnston G. A., Abbenante J., Prager R. H. 2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors. Neurosci Lett. 1988 Sep 23;92(1):92–96. doi: 10.1016/0304-3940(88)90748-3. [DOI] [PubMed] [Google Scholar]
  11. Kerr D. I., Ong J., Prager R. H., Gynther B. D., Curtis D. R. Phaclofen: a peripheral and central baclofen antagonist. Brain Res. 1987 Mar 3;405(1):150–154. doi: 10.1016/0006-8993(87)90999-1. [DOI] [PubMed] [Google Scholar]
  12. Levy R. A., Proudfit H. K. Analgesia produced by microinjection of baclofen and morphine at brain stem sites. Eur J Pharmacol. 1979 Jul 15;57(1):43–55. doi: 10.1016/0014-2999(79)90102-x. [DOI] [PubMed] [Google Scholar]
  13. Levy R. A., Proudfit H. K. The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid]. J Pharmacol Exp Ther. 1977 Aug;202(2):437–445. [PubMed] [Google Scholar]
  14. Liebman J. M., Pastor G. Antinociceptive effects of baclofen and muscimol upon intraventricular administration. Eur J Pharmacol. 1980 Feb 8;61(3):225–230. doi: 10.1016/0014-2999(80)90124-7. [DOI] [PubMed] [Google Scholar]
  15. Olpe H. R., Karlsson G., Pozza M. F., Brugger F., Steinmann M., Van Riezen H., Fagg G., Hall R. G., Froestl W., Bittiger H. CGP 35348: a centrally active blocker of GABAB receptors. Eur J Pharmacol. 1990 Oct 2;187(1):27–38. doi: 10.1016/0014-2999(90)90337-6. [DOI] [PubMed] [Google Scholar]
  16. Robinson T. N., Cross A. J., Green A. R., Toczek J. M., Boar B. R. Effects of the putative antagonists phaclofen and delta-aminovaleric acid on GABAB receptor biochemistry. Br J Pharmacol. 1989 Nov;98(3):833–840. doi: 10.1111/j.1476-5381.1989.tb14612.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sawynok J. Baclofen activates two distinct receptors in the rat spinal cord and guinea pig ileum. Neuropharmacology. 1986 Jul;25(7):795–798. doi: 10.1016/0028-3908(86)90098-5. [DOI] [PubMed] [Google Scholar]
  18. Sawynok J., Dickson C. D-Baclofen is an antagonist at baclofen receptors mediating antinociception in the spinal cord. Pharmacology. 1985;31(5):248–259. doi: 10.1159/000138129. [DOI] [PubMed] [Google Scholar]
  19. Sawynok J., Dickson C. Evidence for the involvement of descending noradrenergic pathways in the antinociceptive effect of baclofen. Brain Res. 1985 May 27;335(1):89–97. doi: 10.1016/0006-8993(85)90279-3. [DOI] [PubMed] [Google Scholar]
  20. Sawynok J. GABAergic mechanisms of analgesia: an update. Pharmacol Biochem Behav. 1987 Feb;26(2):463–474. doi: 10.1016/0091-3057(87)90148-1. [DOI] [PubMed] [Google Scholar]
  21. Sawynok J., LaBella F. S. On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology. 1982 May;21(5):397–403. doi: 10.1016/0028-3908(82)90022-3. [DOI] [PubMed] [Google Scholar]
  22. Sawynok J. Monoamines as mediators of the antinociceptive effect of baclofen. Naunyn Schmiedebergs Arch Pharmacol. 1983 Jun;323(1):54–57. doi: 10.1007/BF00498828. [DOI] [PubMed] [Google Scholar]
  23. Sawynok J., Moochhala S. M., Pillay D. J. Substance P, injected intrathecally, antagonizes the spinal antinociceptive effect of morphine, baclofen and noradrenaline. Neuropharmacology. 1984 Jul;23(7A):741–747. doi: 10.1016/0028-3908(84)90106-0. [DOI] [PubMed] [Google Scholar]
  24. Sawynok J. The 1988 Merck Frosst Award. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies. Can J Physiol Pharmacol. 1989 Sep;67(9):975–988. doi: 10.1139/y89-154. [DOI] [PubMed] [Google Scholar]
  25. Stirling J. M., Cross A. J., Robinson T. N., Green A. R. The effects of GABAB receptor agonists and antagonists on potassium-stimulated [Ca2+]i in rat brain synaptosomes. Neuropharmacology. 1989 Jul;28(7):699–704. doi: 10.1016/0028-3908(89)90153-6. [DOI] [PubMed] [Google Scholar]
  26. Vaught J. L., Pelley K., Costa L. G., Setler P., Enna S. J. A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen. Neuropharmacology. 1985 Mar;24(3):211–216. doi: 10.1016/0028-3908(85)90076-0. [DOI] [PubMed] [Google Scholar]
  27. Wang M. Y., Dun N. J. Phaclofen-insensitive presynaptic inhibitory action of (+/-)-baclofen in neonatal rat motoneurones in vitro. Br J Pharmacol. 1990 Feb;99(2):413–421. doi: 10.1111/j.1476-5381.1990.tb14718.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wilson P. R., Yaksh T. L. Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol. 1978 Oct 15;51(4):323–330. doi: 10.1016/0014-2999(78)90423-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES